BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tamai R, Asai Y, Hashimoto M, Fukase K, Kusumoto S, Ishida H, Kiso M, Ogawa T. Cell activation by monosaccharide lipid A analogues utilizing Toll-like receptor 4. Immunology. 2003;110:66-72. [PMID: 12941142 DOI: 10.1046/j.1365-2567.2003.01709.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Yi H, Yi S, Jang B, Song D, Shin D, Mun K, Kim S, Suh S, Bae JH. Inhibitory effects of glucosamine on lipopolysaccharide‐induced activation in microglial cells. Clinical and Experimental Pharmacology and Physiology 2006;32:1097-103. [DOI: 10.1111/j.1440-1681.2005.04305.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
2 Peri F, Granucci F, Costa B, Zanoni I, Marinzi C, Nicotra F. Inhibition of Lipid A Stimulated Activation of Human Dendritic Cells and Macrophages by Amino and Hydroxylamino Monosaccharides. Angew Chem 2007;119:3372-6. [DOI: 10.1002/ange.200604932] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
3 Bowen WS, Gandhapudi SK, Kolb JP, Mitchell TC. Immunopharmacology of Lipid A Mimetics. Immunopharmacology. Elsevier; 2013. pp. 81-128. [DOI: 10.1016/b978-0-12-404717-4.00003-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Peri F, Piazza M, Calabrese V, Damore G, Cighetti R. Exploring the LPS/TLR4 signal pathway with small molecules. Biochem Soc Trans. 2010;38:1390-1395. [PMID: 20863319 DOI: 10.1042/bst0381390] [Cited by in Crossref: 66] [Cited by in F6Publishing: 26] [Article Influence: 6.6] [Reference Citation Analysis]
5 Ogawa T, Yagi T. Bioactive mechanism of Porphyromonas gingivalis lipid A. Periodontol 2000 2010;54:71-7. [PMID: 20712634 DOI: 10.1111/j.1600-0757.2009.00343.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
6 Montoya CJ, Rugeles MT, Landay AL. Innate immune defenses in HIV-1 infection: prospects for a novel immune therapy. Expert Rev Anti Infect Ther 2006;4:767-80. [PMID: 17140354 DOI: 10.1586/14787210.4.5.767] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
7 Kaszubowska L, Foerster J, Kaczor JJ, Schetz D, Ślebioda TJ, Kmieć Z. NK cells of the oldest seniors represent constant and resistant to stimulation high expression of cellular protective proteins SIRT1 and HSP70. Immun Ageing 2018;15:12. [PMID: 29541147 DOI: 10.1186/s12979-018-0115-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
8 Kaszubowska L, Foerster J, Schetz D, Kmieć Z. CD56bright cells respond to stimulation until very advanced age revealing increased expression of cellular protective proteins SIRT1, HSP70 and SOD2. Immun Ageing 2018;15:31. [PMID: 30534181 DOI: 10.1186/s12979-018-0136-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Seo H, Masuda H, Asagoshi K, Uchiki T, Kawata S, Sasaki G, Yabuki T, Miyai S, Takahashi N, Hashimoto SI, Sawada A, Takaiwa A, Koyama C, Tamai K, Kurosawa K, Lin KY, Ohta K, Nakazaki Y. Streamlined human antibody generation and optimization by exploiting designed immunoglobulin loci in a B cell line. Cell Mol Immunol 2021;18:1545-61. [PMID: 32457406 DOI: 10.1038/s41423-020-0440-9] [Reference Citation Analysis]
10 Facchini FA, Zaffaroni L, Minotti A, Rapisarda S, Calabrese V, Forcella M, Fusi P, Airoldi C, Ciaramelli C, Billod JM, Schromm AB, Braun H, Palmer C, Beyaert R, Lapenta F, Jerala R, Pirianov G, Martin-Santamaria S, Peri F. Structure-Activity Relationship in Monosaccharide-Based Toll-Like Receptor 4 (TLR4) Antagonists. J Med Chem 2018;61:2895-909. [PMID: 29494148 DOI: 10.1021/acs.jmedchem.7b01803] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
11 Pifferi C, Fuentes R, Fernández-Tejada A. Natural and synthetic carbohydrate-based vaccine adjuvants and their mechanisms of action. Nat Rev Chem 2021;:1-20. [PMID: 33521324 DOI: 10.1038/s41570-020-00244-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
12 Sándor V, Dörnyei Á, Makszin L, Kilár F, Péterfi Z, Kocsis B, Kilár A. Characterization of complex, heterogeneous lipid A samples using HPLC-MS/MS technique I. Overall analysis with respect to acylation, phosphorylation and isobaric distribution. J Mass Spectrom 2016;51:1043-63. [PMID: 27506631 DOI: 10.1002/jms.3839] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
13 Tamai R, Sugamata M, Kiyoura Y. Amphotericin B up-regulates lipid A-induced IL-6 production via caspase-8. J Dent Res 2012;91:709-14. [PMID: 22538414 DOI: 10.1177/0022034512446486] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
14 Kanevskiy LM, Telford WG, Sapozhnikov AM, Kovalenko EI. Lipopolysaccharide induces IFN-γ production in human NK cells. Front Immunol 2013;4:11. [PMID: 23372571 DOI: 10.3389/fimmu.2013.00011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 4.9] [Reference Citation Analysis]
15 Calvopina M, Barroso PA, Marco JD, Korenaga M, Cooper PJ, Nonaka S, Hashiguchi Y. Efficacy of vaccination with a combination of Leishmania amastigote antigens and the lipid A-analogue ONO-4007 for immunoprophylaxis and immunotherapy against Leishmania amazonensis infection in a murine model of New World cutaneous leishmaniasis. Vaccine 2006;24:5645-52. [PMID: 16621179 DOI: 10.1016/j.vaccine.2006.03.023] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
16 Karaś MA, Turska-Szewczuk A, Janczarek M, Szuster-Ciesielska A. Glycoconjugates of Gram-negative bacteria and parasitic protozoa - are they similar in orchestrating the innate immune response? Innate Immun 2019;25:73-96. [PMID: 30782045 DOI: 10.1177/1753425918821168] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Erridge C, Pridmore A, Eley A, Stewart J, Poxton IR. Lipopolysaccharides of Bacteroides fragilis, Chlamydia trachomatis and Pseudomonas aeruginosa signal via toll-like receptor 2. J Med Microbiol 2004;53:735-40. [PMID: 15272059 DOI: 10.1099/jmm.0.45598-0] [Cited by in Crossref: 132] [Cited by in F6Publishing: 125] [Article Influence: 7.8] [Reference Citation Analysis]
18 El-Obeid A, Hassib A, Pontén F, Westermark B. Effect of herbal melanin on IL-8: a possible role of Toll-like receptor 4 (TLR4). Biochem Biophys Res Commun 2006;344:1200-6. [PMID: 16650380 DOI: 10.1016/j.bbrc.2006.04.035] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
19 Savov JD, Brass DM, Lawson BL, McElvania-Tekippe E, Walker JK, Schwartz DA. Toll-like receptor 4 antagonist (E5564) prevents the chronic airway response to inhaled lipopolysaccharide. Am J Physiol Lung Cell Mol Physiol 2005;289:L329-37. [PMID: 15833764 DOI: 10.1152/ajplung.00014.2005] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
20 Tamai R, Kiyoura Y. Alendronate augments lipid A-induced IL-1β release and Smad3/NLRP3/ASC-dependent cell death. Life Sciences 2018;198:8-17. [DOI: 10.1016/j.lfs.2018.02.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
21 Fujimoto Y, Adachi Y, Akamatsu M, Fukase Y, Kataoka M, Suda Y, Fukase K, Kusumoto S. Synthesis of lipid A and its analogues for investigation of the structural basis for their bioactivity. Journal of Endotoxin Research 2005;11:341-7. [DOI: 10.1177/09680519050110060901] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 5.2] [Reference Citation Analysis]
22 Peri F, Granucci F, Costa B, Zanoni I, Marinzi C, Nicotra F. Inhibition of Lipid A Stimulated Activation of Human Dendritic Cells and Macrophages by Amino and Hydroxylamino Monosaccharides. Angew Chem Int Ed 2007;46:3308-12. [DOI: 10.1002/anie.200604932] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
23 Dixon DR, Darveau RP. Lipopolysaccharide heterogeneity: innate host responses to bacterial modification of lipid a structure. J Dent Res. 2005;84:584-595. [PMID: 15972584 DOI: 10.1177/154405910508400702] [Cited by in Crossref: 143] [Cited by in F6Publishing: 136] [Article Influence: 8.9] [Reference Citation Analysis]
24 Cighetti R, Ciaramelli C, Sestito SE, Zanoni I, Kubik Ł, Ardá-Freire A, Calabrese V, Granucci F, Jerala R, Martín-Santamaría S, Jiménez-Barbero J, Peri F. Modulation of CD14 and TLR4·MD-2 activities by a synthetic lipid A mimetic. Chembiochem 2014;15:250-8. [PMID: 24339336 DOI: 10.1002/cbic.201300588] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
25 Cochet F, Facchini FA, Zaffaroni L, Billod JM, Coelho H, Holgado A, Braun H, Beyaert R, Jerala R, Jimenez-Barbero J, Martin-Santamaria S, Peri F. Novel carboxylate-based glycolipids: TLR4 antagonism, MD-2 binding and self-assembly properties. Sci Rep 2019;9:919. [PMID: 30696900 DOI: 10.1038/s41598-018-37421-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
26 Peng Y, Gong JP, Liu CA, Li XH, Gan L, Li SB. Expression of toll-like receptor 4 and MD-2 gene and protein in Kupffer cells after ischemia-reperfu-sion in rat liver graft. World J Gastroenterol. 2004;10:2890-2893. [PMID: 15334694 DOI: 10.3748/wjg.v10.i19.2890] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
27 Zughaier S, Steeghs L, van der Ley P, Stephens DS. TLR4-dependent adjuvant activity of Neisseria meningitidis lipid A. Vaccine 2007;25:4401-9. [PMID: 17466419 DOI: 10.1016/j.vaccine.2007.03.029] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
28 Cochet F, Peri F. The Role of Carbohydrates in the Lipopolysaccharide (LPS)/Toll-Like Receptor 4 (TLR4) Signalling. Int J Mol Sci 2017;18:E2318. [PMID: 29099761 DOI: 10.3390/ijms18112318] [Cited by in Crossref: 66] [Cited by in F6Publishing: 49] [Article Influence: 16.5] [Reference Citation Analysis]
29 Bazin HG, Bess LS, Livesay MT, Ryter KT, Johnson CL, Arnold JS, Johnson DA. New synthesis of glycolipid immunostimulants RC-529 and CRX-524. Tetrahedron Letters 2006;47:2087-92. [DOI: 10.1016/j.tetlet.2006.01.137] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
30 Zughaier SM, Zimmer SM, Datta A, Carlson RW, Stephens DS. Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins. Infect Immun 2005;73:2940-50. [PMID: 15845500 DOI: 10.1128/IAI.73.5.2940-2950.2005] [Cited by in Crossref: 140] [Cited by in F6Publishing: 81] [Article Influence: 8.8] [Reference Citation Analysis]
31 Bazin HG, Murray TJ, Bowen WS, Mozaffarian A, Fling SP, Bess LS, Livesay MT, Arnold JS, Johnson CL, Ryter KT, Cluff CW, Evans JT, Johnson DA. The 'Ethereal' nature of TLR4 agonism and antagonism in the AGP class of lipid A mimetics. Bioorg Med Chem Lett 2008;18:5350-4. [PMID: 18835160 DOI: 10.1016/j.bmcl.2008.09.060] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
32 Zubova SV, Grachev SV, Prokhorenko IR. Effect of lipopolysaccharide structure on functional response of whole blood cells. Immunobiology 2021;226:152030. [PMID: 33278708 DOI: 10.1016/j.imbio.2020.152030] [Reference Citation Analysis]
33 Jungi TW, Farhat K, Burgener IA, Werling D. Toll-like receptors in domestic animals. Cell Tissue Res 2011;343:107-20. [DOI: 10.1007/s00441-010-1047-8] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 4.1] [Reference Citation Analysis]
34 Askenase PW, Itakura A, Leite-de-moraes MC, Lisbonne M, Roongapinun S, Goldstein DR, Szczepanik M. TLR-Dependent IL-4 Production by Invariant Vα14 + Jα18 + NKT Cells to Initiate Contact Sensitivity In Vivo. J Immunol 2005;175:6390-401. [DOI: 10.4049/jimmunol.175.10.6390] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
35 Stöver AG, Da Silva Correia J, Evans JT, Cluff CW, Elliott MW, Jeffery EW, Johnson DA, Lacy MJ, Baldridge JR, Probst P, Ulevitch RJ, Persing DH, Hershberg RM. Structure-Activity Relationship of Synthetic Toll-like Receptor 4 Agonists. Journal of Biological Chemistry 2004;279:4440-9. [DOI: 10.1074/jbc.m310760200] [Cited by in Crossref: 111] [Cited by in F6Publishing: 48] [Article Influence: 6.5] [Reference Citation Analysis]
36 Véran J, Mohty M, Gaugler B, Chiavaroli C, Olive D. OM-197-MP-AC adjuvant properties: the in vitro maturation of normal and leukemic dendritic cells in a serum-free culture model. Immunobiology 2004;209:67-77. [DOI: 10.1016/j.imbio.2004.02.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
37 Akamatsu M, Fujimoto Y, Kataoka M, Suda Y, Kusumoto S, Fukase K. Synthesis of lipid A monosaccharide analogues containing acidic amino acid: exploring the structural basis for the endotoxic and antagonistic activities. Bioorg Med Chem 2006;14:6759-77. [PMID: 16828560 DOI: 10.1016/j.bmc.2006.05.051] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
38 Saikh KU, Kissner TL, Sultana A, Ruthel G, Ulrich RG. Human monocytes infected with Yersinia pestis express cell surface TLR9 and differentiate into dendritic cells. J Immunol 2004;173:7426-34. [PMID: 15585868 DOI: 10.4049/jimmunol.173.12.7426] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
39 Facchini FA, Coelho H, Sestito SE, Delgado S, Minotti A, Andreu D, Jiménez-Barbero J, Peri F. Co-administration of Antimicrobial Peptides Enhances Toll-like Receptor 4 Antagonist Activity of a Synthetic Glycolipid. ChemMedChem 2018;13:280-7. [PMID: 29265636 DOI: 10.1002/cmdc.201700694] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
40 Nagel M, Brauckmann S, Moegle-hofacker F, Effenberger-neidnicht K, Hartmann M, de Groot H, Mayer C. Impact of bacterial endotoxin on the structure of DMPC membranes. Biochimica et Biophysica Acta (BBA) - Biomembranes 2015;1848:2271-6. [DOI: 10.1016/j.bbamem.2015.06.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]